HIGHLIGHTS
- who: Dongen Ju from the Medical University of South Carolina, United States have published the article: FBP1/miR-24-1/enhancer axis activation blocks renal cell carcinoma progression via Warburg effect, in the Journal: (JOURNAL)
- what: The work demonstrated that overexpression of miR-24-1 can activate FBP1 to block RCC proliferation and metastasis , shedding a light on the unconventional role of miRNAs in malignancies. The work showed that deletion of miR-24-1 reduces enhancer activity in RCC, nevertheless, enhancer inactivation leads to low expression of FBP1, which in turn promoted the Warburg effect . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.